Delivery Order SPE2D018D0005-SPE2D325F089Z
Award Date
5/28/25
Potential Completion Date
6/2/25
Potential Value
$4.6K
Federal Agency
Medical Supply Chain
Awardee
Ortho-Clinical Diagnostics, Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,985.58 firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the provision of "BLOOD GROUP SERUM" and does not have a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture registered in SAM.gov and specializes in supplying sophisticated medical...
This is a delivery order award from the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer located in Raritan, New Jersey. The award, valued at $2,822.82, is for the supply of REAGENT ANTI-A 10ML 3S, a medical reagent used for diagnostic testing. The award is not associated with a set-aside program and was competitively awarded. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and manufacturer of goods, with a...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense agency. The contract is for the delivery of REAGENT ANTI-A B BIOCLONE 10ML BOTTLE OR, a medical diagnostic product. The contract is a Delivery Order with a Firm Fixed Price of $1,963.68 and an ultimate completion date of April 21, 2025. There is no set-aside designation for this contract. Ortho-Clinical Diagnostics, Inc. is a...
This is a $1,832.54 delivery order awarded by the Medical Supply Chain, a division of the Defense agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the supply of "ANTI-A BIOCLONE 15X10ML", a medical diagnostic product, with a period of performance through May 2025. The contract has a fixed price with economic price adjustment pricing type and does not utilize any set-aside designations. Ortho-Clinical Diagnostics, Inc. is a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture. The $1,963.68 contract is for the supply of REAGENT ANTI-A B BIOCLONE 10ML BOTTLE OR, with a completion date of June 4, 2024. The contract does not have a set-aside designation. Ortho-Clinical Diagnostics, Inc. has provided a range of diagnostic solutions, medical...
This is a $1,767.32 fixed-price delivery order awarded by the Medical Supply Chain, a component of the Defense Logistics Agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer registered in SAM.gov as a self-certified HUBZone joint venture. The contract is for the supply of anti-A,B bioclone laboratory reagents, with a period of performance through February 2025. Ortho-Clinical Diagnostics has demonstrated the capability to provide critical medical diagnostic...
This federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturing company, was issued by the Defense Logistics Agency Troop Support Medical, part of the Department of Defense. The $2,748.81 firm fixed-price delivery order is for 4,564,275,330 units of an anti-A blood grouping reagent used in clinical laboratory applications. The award has no set-aside designation and an ultimate completion date of April 18, 2024. Ortho-Clinical Diagnostics has provided...
This federal contract award to Ortho-Clinical Diagnostics, Inc., a self-certified HUBZone joint venture manufacturer, was issued by the Medical Supply Chain division of the Defense Logistics Agency. The $2,869.77 firm-fixed-price delivery order is for the supply of 150 ml bottles of Reagent Anti-D Bioclone, a critical medical reagent. The contract has an ultimate completion date of October 3, 2024. Ortho-Clinical Diagnostics has previously provided a range of medical equipment, reagents, and...
This is a $4,418.30 fixed-price delivery order awarded to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer, by the Defense Health Agency for blood group serum supplies. The order has a period of performance ending on November 29, 2024. Ortho-Clinical Diagnostics is a for-profit organization and self-certified HUBZone joint venture that has previously provided medical equipment, reagents, and testing services to federal agencies including the Department of Veterans Affairs and...
This is a delivery order award to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer, by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense. The award, valued at $11,782.29, is for the delivery of 4566034359 - REAGENT ANTI-A 10ML 3S. The contract is a fixed price with economic price adjustment type and has an ultimate completion date of October 28, 2024. Ortho-Clinical Diagnostics is a for-profit organization and self-certified HUBZone...